Evidence map›Paper›PMID 35530199›Full record

ArticleRSC advances2019

Characterization and comparison of

Yi Zhang, Brian Chi-Yan Cheng, Cui Li, Yonghua Tao, Chanjuan Yu, Xinyue Liu, Xiaoyan Gao, Gan Luo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Yi ZhangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine Beijing 100102 China.ORCID https://orcid.org/0000-0002-4168-1311
Brian Chi-Yan ChengCollege of Professional and Continuing Education, Hong Kong Polytechnic University Hong Kong 999077 China.
Cui LiChina Institute of Chinese Materia Medica, China Academy of Chinese Medical Science Beijing 100700 China.
Yonghua TaoIncrease Pharm (Tianjin) Institute Co., Ltd Tianjin 300382 China.
Chanjuan YuSchool of Chinese Materia Medica, Beijing University of Chinese Medicine Beijing 100102 China.
Xinyue LiuSchool of Chinese Materia Medica, Beijing University of Chinese Medicine Beijing 100102 China.
Xiaoyan GaoSchool of Chinese Materia Medica, Beijing University of Chinese Medicine Beijing 100102 China.
Gan LuoSchool of Chinese Materia Medica, Beijing University of Chinese Medicine Beijing 100102 China.ORCID https://orcid.org/0000-0002-3644-5752
Beijing University of Chinese Medicine · CNHong Kong Polytechnic University · HKTianjin Institute of Pharmaceutical Research (China) · CNXinjiang Institute of Materia Medica · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inhalation therapy is the first-line therapy for the treatment of respiratory diseases.

Identifiers

PMID35530199
PMCPMC9072082
OpenAlexW2976416505

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.